These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18466996)

  • 1. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
    Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers.
    Libbrecht L; Cassiman D; Verslype C; Maleux G; Van Hees D; Pirenne J; Nevens F; Roskams T
    Am J Gastroenterol; 2006 Oct; 101(10):2341-6. PubMed ID: 17032200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
    Bioulac-Sage P; Laumonier H; Rullier A; Cubel G; Laurent C; Zucman-Rossi J; Balabaud C
    Liver Int; 2009 Mar; 29(3):459-65. PubMed ID: 18803590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas.
    Braeuning A; Ittrich C; Köhle C; Buchmann A; Schwarz M
    Drug Metab Dispos; 2007 Apr; 35(4):503-7. PubMed ID: 17220236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
    Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules?
    Nakashima O; Kurogi M; Yamaguchi R; Miyaaki H; Fujimoto M; Yano H; Kumabe T; Hayabuchi N; Hisatomi J; Sata M; Kojiro M
    J Hepatol; 2004 Dec; 41(6):992-8. PubMed ID: 15582133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
    Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
    J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
    Braeuning A; Menzel M; Kleinschnitz EM; Harada N; Tamai Y; Köhle C; Buchmann A; Schwarz M
    FEBS J; 2007 Sep; 274(18):4766-77. PubMed ID: 17697114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
    Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
    Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
    Pan Y; Wang ZM; Mou LJ; Teng XD; Zheng ZJ; Ying LX
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):199-203. PubMed ID: 15138109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
    J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
    Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
    J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.